Pharma link to positive antiviral findings

Experts who conducted systematic reviews on neuraminidase inhibitors were far more likely to recommend use of the drugs if they had financial ties to the pharma industry, Australian-funded research finds.

Stockpiling the antivirals in the event of an influenza pandemic has cost governments $6.9 billion worldwide.